98
Participants
Start Date
October 31, 2024
Primary Completion Date
July 15, 2025
Study Completion Date
July 15, 2025
ZX-7101A
On day1: Take two tablets of ZX-7101A orally once (specification: 10mg/ tablet) with appropriate amount of warm water
Placebo for ZX-7101A tablet
"Placebo for ZX-7101A tablet:~The appearance and properties of placebo tablets were identical to those of the trial drug ZX-7101A tablets. On Day 1, two placebo for ZX-7101A tablets were taken orally with appropriate warm water."
Oseltamivir phosphate dry suspension
"Drug: Oseltamivir phosphate dry suspension:~From Day1 to Day 5 : Oseltamivir phosphate suspension was orally administered twice a day, dose according to the label."
Placebo for Oseltamivir phosphate dry suspension:
"Drug: Placebo for Oseltamivir phosphate dry suspension:~From Day1 to Day 5 : Placebo for Oseltamivir phosphate suspension was orally administered twice a day, dose according to the label."
Baoding Hospital of Beijing Children's Hospital, Capital Medical University, Baoding
West China Second University Hospital, Sichuan University, Chengdu
Children's Hospital Zhejiang University School of Medicine, Hangzhou
Lead Sponsor
Nanjing Zenshine Pharmaceuticals
INDUSTRY